Covid-19 pins geographic needles in Ambu's core business – CEO hopes for stabilization ahead

Ambu's sales of single-use endoscopes moves forward in certain markets but plummets in others, and the murky picture can be tracked along the lines of the coronavirus' geographic and chronological movement, says CEO Juan Jose Gonzalez, who is pleased about the consolidated outlook and markets stabilizing.

Ambus topchef Juan Jose Gonzalez bruger helst helikopter-perspektivet, når han vurderer væksten i selskabets kerneforretning. | Photo: Ambu/PR

Compared to last year, sales growth for single-use endoscopes seems to have reached a standstill at Ambu.

In recent years, the Danish medical group has been investing heavily in the sale of disposable endoscopes, which is the company's growth engine.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs